Abstract
Hepatocellular carcinoma (HCC) is responsible for 90% of primary hepatic cancer cases, and its incidence with associated morbidity and mortality is growing worldwide. In recent decades, there has been a revolution in HCC treatment. There are three main types of locoregional therapy: radiofrequency ablation, transarterial chemoembolisation, and transarterial radioembolisation. This article summarises recent advances in locoregional methods.
| Original language | English |
|---|---|
| Article number | 3347 |
| Number of pages | 16 |
| Journal | Cancers |
| Volume | 15 |
| Issue number | 13 |
| Early online date | 26 Jun 2023 |
| DOIs | |
| Publication status | Published - 1 Jul 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- hepatocellular carcinoma
- liver neoplasms
- radiofrequency ablation
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver